PHARMACOKINETIC DIFFERENCES OF DESMETHYLDIAZEPAM IN 3 OUTBRED WISTAR STRAINS RELATED TO DIFFERENCES IN LIVER-ENZYME ACTIVITIES

Citation
Jw. Vanderlaan et al., PHARMACOKINETIC DIFFERENCES OF DESMETHYLDIAZEPAM IN 3 OUTBRED WISTAR STRAINS RELATED TO DIFFERENCES IN LIVER-ENZYME ACTIVITIES, Pharmacology & toxicology, 73(4), 1993, pp. 229-232
Citations number
29
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
Journal title
ISSN journal
09019928
Volume
73
Issue
4
Year of publication
1993
Pages
229 - 232
Database
ISI
SICI code
0901-9928(1993)73:4<229:PDODI3>2.0.ZU;2-#
Abstract
Various strains of rats differ in their sensitivities towards benzodia zepines suggesting that variations in biological features are responsi ble for these differences. All reports concern inbred strains. We have studied male rats of three outbred Wistar strains with regard to the pharmacokinetics of desmethyldiazepam given as a single intravenous do se. The elimination half-life of desmethyldiazepam was longer in the R iv:TOX(M) (from the National Institute of Public Health and Environmen tal Protection) and in the Cpb:WU strain than in the Crl:(WI)BR strain . This strain difference in elimination of desmethyldiazepam may be re lated to differences in liver enzyme activities.